VALIDATION OF COMPUTERISED SYSTEMS IN THE PHARMACEUTICAL INDUSTRY Matt Safi Product manager.

Slides:



Advertisements
Similar presentations
How to Validate a Vendor Purchased Application
Advertisements

EPAA Annual conference November Regulatory acceptance of alternative approaches for pharmaceuticals Jean-Marc Vidal Safety & Efficacy of Human Medicines.
Chapter 20 REGULATIONS IN BIOTECHNOLOGY. Regulations Are intended to allow us to safely use the benefits of biotech. Help in developing and using biotech.
21 CFR Part 11 course syllabus / Ilan Shaya 21CFR Pat 11 | Objective | Audience |Course Outline | Details 15-16/7/2013.
Biopharmaceutical Quality
Radiopharmaceutical Production
The New GMP Annex 11 and Chapter 4 Deadline for coming into operation: 30 June 2011.
Audit of IT Systems SARQA / DKG Scandinavian Conference, October 2002, Copenhagen Sue Gregory.
Regulatory Compliant Performance Improvement for Pharmaceutical Plants AIChE New Jersey Section 01/13/2004 Murugan Govindasamy Pfizer Inc.
Introduction to PPDs Regulatory requirements and rationale.
Integrating CMC Review & Inspection Industry Recommendations Joe Anisko April 24, 2003.
Public and Private Interests in Animal Research LAT Chapter 1.
Manufacturing Subcommittee of the Advisory Committee for Pharmaceutical Science July 20-21, 2004 Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical.
CDRH Software Regulation
Validation Tutorial This tutorial is designed to enhance knowledge of biotechnological/pharmaceutical processes. The topics covered within this tutorial.
Regulatory requirements and benefits converting to Continued Process Verification.
21 CFR Part 11 A Food Industry Perspective FDA Public Meeting June 11, 2004 Sia Economides Center Director Center for Development of Research Policy and.
Good Clinical Practice GCP
DRAFT Richard Chandler-Mant – R Consultant The Challenges of Validating R Managing R in a Commercial Environment.
Consumer Protection. Testing Quantitative Test ( measurable) Qualitative Testing (opinions) Sensory Testing (opinions)
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
MethodGXP The Solution for the Confusion.
Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407.
Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.
INTRODUCTION TO RA.
RAISING THE BAR Meeting CSA Guidelines And Preparing for Health Canada
Clinical Trial Review and Approval: New Regulations and their implications Siddika Mithani, Ph.D Clinical Trials & Special Access Programme Therapeutic.
Drug Submissions: Review Process Agnes V. Klein, MD Biologics and Genetic Therapies Directorate February, 2003 www/hc-sc.gc.ca/hpb-dgps/therapeut.
Lecture Topic 4: Good Manufacturing Practices (GMPs)
SAHPRA proposals Nov 2009 A GLIMPSE OF WHAT SAHPRA IS INTENDED TO BECOME KEY PROPOSALS FOR SAHPRA NOVEMBER 2009 DR NICHOLAS CRISP.
Important informations
1 Regulatory Aspects of Pharmaceutical Excipients PQRI Workshop Nick Buhay Acting Director Division of Manufacturing and Product Quality Office of Compliance.
This class cannot be shared or copied without the written permission of PracticeWorks Systems, LLC.
Part 11, Electronic Records; Electronic Signatures
Molecule-to-Market-Place Quality
Over View of CENELC Standards for Signalling Applications
Agenda for Session Compliance in Clinical Research
Module C FDA Regulations Regulatory Documents Patricia E. Koziol 1Module C Final Version 10-apr-2010.
+ION A REPORT ON MANUFACTURING REGULATION. TABLE CONTENTS INTRO DATE OF INCEPTION MANDATE OR VISION STAEMENT VOLUNTARY OR MANITORY PRACTICE LINKS JURISDICTION.
CDER / Office of Compliance ACPS October 5, 2006 Joseph C. Famulare Acting Deputy Director Office of Compliance CDER / FDA.
Second Meeting of the FDA/ACPS Process Analytical Technology: Closing Remarks Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical Sciences.
The CDRH Software Message (October 19, 2002) John F Murray Jr.. Center for Devices & Radiological Health US Food and Drug Administration
Workshop on Accreditation of Bodies Certifying Medical Devices Kiev, November 2014.
Implementation of PANDRH Guidelines NAFTA Region VI PANDRH Conference Brasilia, July 2-8, 2011 Justina Molzon -- US Food and Drug Administration Mike Ward.
Good Laboratory Practice - general information Pirkko Puranen Senior Inspector, Ph.D. Inspectorate.
Biotech Regulations Modified by Georgia Agricultural Education Curriculum Office June, 2002.
Guidance Development Merton V. Smith, Ph.D., J.D. Director International Programs and Product Standards Center for Veterinary Medicine, FDA.
FDA 21 CFR Part 11 Compliance
Author: Nurul Azyyati Sabri
Good Manufacturing Practices
Contingent Workforce: Cerner Quality System & Regulations
Международные требования к использованию электронных систем в клинических исследованиях Timur Galimov, CTO.
Clinical Trials Validation, 21 CFR Part 11 Compliance
GOOD MANUFACTURING PRACTICE FOR BIOPROCESS ENGINEERING (ERT 425)
Modified by Georgia Agricultural Education Curriculum Office
Pharmaceutical Quality Control & current Good Manufacturing Practice
Author: Nurul Azyyati Sabri
ICH-GCP Avinash Kondawar M. Pharm Lead CRA
How to Apply for and Receive Industry Funding for Investigator Sponsored Research Chuck Simonton MD, FACC, FSCAI Chief Medical Officer Abbott Vascular.
Presentation on Good Manufacturing Practice
Quality System.
Introduction to GMP.
Lesson 8: BRITE Seminar: GMP II
OECD Principles of GLP and Test Guidelines
בקרה תוך שימוש ב 21CFR Part 11 / אילן שעיה סמארט לוג'יק
FDA 21 CFR Part 11 Overview June 10, 2006.
NDOH Perspectives on Regulated
Importance of Standardization James Hammond, Standards Division
Computer System Validation
Radiopharmaceutical Production
Presentation transcript:

VALIDATION OF COMPUTERISED SYSTEMS IN THE PHARMACEUTICAL INDUSTRY Matt Safi Product manager

What does need validation? l Any drugs manufactured for use by humans and animals needs to be validated. l A satisfactory inspection and approval by a regulatory inspector is required before a drug is released for sale.

What is validated? The Process of manufacturing a drug

What is Process Validation? “Validation is documented evidence that provides a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes” FDA

Documentary evidence? “If ain’t written, it ain’t done” Sam Clarke (FDA inspector), 1993

Principles of validation l Document what is to be done l Document how it is to be done l Do it l Produce documented evidence that it was done in accordance with the “how” l Demonstrate that it remains in a state of control

Who is responsible for validation? The manufacturer of a drug is responsible for getting the process validated

What is FDA validation? l FDA (Food & Drug Administration) is responsible for granting approval for drugs intended for the use by humans and animals within the US.

Does every drug need FDA validation? l No, only drugs which are intended for use within USA. l Generally every country has its own regulatory body l MCA (Medicines Control Agency): regulatory body in the UK. l FDA has the most stringent requirement

Can a Computerised system claimed to be FDA validated? l No. Only the process can be validated. l If a system has been used in a validated process then it will help the validation process

Regulators requirements Computerised systems installed in pharmaceutical companies are fit for their intended purposes (in the context of relevant GMPs) by considering: v Quality assurance of the development life-cycle v Performance validation v In-use controls v Accuracy and reliability

Pharmaceutical Company Requirements Computerised systems requirements: v Quality assured, robust, reliable system delivered on time within budget v Meet functional and business targets v Acceptable to regulatory agencies v Ease of maintenance

Cost of poor quality l Denial of product approval l Increased regulatory scrutiny l Seizure of product l Increased cost of implementation and maintenance

What is our responsibility? l Ensure that the supplied automation system satisfies the requirement specification l Provide documentary evidence. l Documentary evidence will be integrated with the overall documentation for submission to the inspector

Some of the regulators l FDA: Federal Drug Administration (US) l HPB: Health Protection Branch (Canada) l Irish Medicines Board l MCA: Medicines Control Agencies (UK) l TGA: Therapeutic Goods Administration (AUS)

Some of the regulations & guidelines l EU 91/EEC/ Good Manufacturing Practice l CFR 201/211 Current Good Manufacturing Practice l FDA Guide to Inspection of Computers Systems l FDA Guide to Soft ware development l FDA Compliance Policy Guidelines l FDA Computerised Systems in Clinical Trials (Draft 1998) l APV Interpretation of Annex 11 (1996), 91/EEC/356 l GAMP Guide l PDA Technical Report 18- Computer Validation